May is Hepatitis Awareness Month, and May 19 marks National Hepatitis Testing Day. By employing widespread screening and vaccination, in accordance with CDC guidelines, most viral hepatitis can be treated or prevented. Both hepatitis A and hepatitis B are easily preventable through routine vaccination. Hepatitis A vaccination is recommended for all children and for adults with risk factors for exposure to this acute infection. Hepatitis B, a cause of both acute and chronic infection, is preventable through routine infant vaccination and catch-up vaccination of everyone through age 59 years. Hepatitis C is not vaccine-preventable but is treatable. See Immunize​.org’s extensive sets of clinical resources and Ask the Experts web pages on each of these important vaccines.

    

Promote Hepatitis Awareness Month and National Hepatitis Testing Day with social media posts. See the Hepatitis Awareness Month Social Media Toolkit for graphics and sample messages to use this May.

Related Links

In collaboration with CDC, Medscape released a text-based educational activity for healthcare professionals: Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months—United States, April 2024.

To view the activity and earn CME, CNE, CPE, or interprofessional credit, click here.

Back to top

---

Alliance for a Healthier Generation shares vaccine resources for caregivers, schools, and communities

The Alliance for a Healthier Generation is a nonprofit organization that works with schools, youth-serving organizations, businesses, and communities across the nation to transform the places kids spend their time into healthier environments. They are now offering vaccine resources centered around caregivers, schools, and communities.

• Vaccination Resources for Schools and Communities: Resources on how to protect students from preventable diseases by ensuring they are up to date on childhood vaccinations
• Vaccines for School Attendance: How to Effectively Communicate with Parents and Caregivers: Approaches to effectively communicate about vaccines 
• Ask a Doctor: What Caregivers Need to Know About the HPV Vaccine: Information on HPV vaccine and cancer prevention 
• Engage Families to Address Student Health: A 10-minute microactivity to engage families in student health initiatives

Back to top

---

Give your adult patients the vaccinations they need every time. Order laminated 2025 U.S. adult immunization schedule booklets. Childhood booklets are sold out.

Laminated booklets of the 2025 U.S. adult immunization schedule are still available in the Immunize​.org shop. The 2025 child and adolescent schedule booklets sold out.

The schedules are available online as PDFs from CDC at no cost. Immunize​.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:

• Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
• Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages.
• Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize​.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
• Bonus content: The schedule includes a bonus page with Immunize​.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.

    


Pricing:

Adult Booklets 

1 copy: $10.00
2–4 copies: $9.50 each
5–19 copies: $8.50 each
20–99 copies: $7.50 each
100–499 copies: $6.00 each
500–999 copies: $5.00 each
1,000–1,999 copies: $4.00 each
2,000+ copies: $3.25 each

Visit the Shop Immunize​.org: Laminated Schedules web page to view images and order today!

For additional information, call 651-647-9009 or email [email protected].

Related Links

• Immunize​.org: Laminated Adult Immunization Schedules (19 and older) web page
• Immunize​.org: Shop Immunize​.org main page 

Back to top

Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one. To help you maximize patient protection, Immunize​.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense website.



This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:

• Influenza in Adults 65+: The Facts
• Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP
• The Importance of Preventing Influenza and COVID-19

Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.

Check out the updated 65+ Flu Defense website to assist your ongoing efforts in protecting this vulnerable population.

Immunize​.org’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75". The pin features a stick-through-post with the back covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.


Wear these pins on clothing, uniforms, and white coats to show that you value vaccines.



Click here for "Vaccines Save Lives" pin pricing and ordering information.

In the January 2025 issue, eClinicalMedicine published Real-World Effectiveness and Causal Mediation Study of BNT162b2 on Long COVID Risks in Children and Adolescents. Portions of the Summary and Research-in-Context sections appear below.

 During the Delta period, the estimated effectiveness of the [Pfizer/BioNTech] BNT162b2 vaccine against long COVID among adolescents was 95.4%  . . . During the Omicron phase, the estimated effectiveness against long COVID among children was 60.2% . . . and 75.1% . . . among adolescents. . . .

Our study found a high overall protective effect of BNT162b2 against long COVID during Delta period, and moderate protective effects during the Omicron period. The estimated direct and indirect effects indicated that the vaccine’s primary advantage in protecting against long COVID outcomes stems from its ability to reduce the risk of SARS-CoV-2 infection in both Delta and Omicron period. . . .

Given that the causal pathways for developing long COVID are still not fully understood, our findings underscore the importance of continually prioritizing the prevention of SARS-CoV-2 infections and using vaccination as a key focus of public health policy to mitigate the risk of long COVID.

In the April 24 issue, JAMA published Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the U.S. This study estimates the consequences of declining vaccination rates over time, including the re-establishment of measles as an endemic disease in the United States. Portions of the abstract appear below.

Results: At current state-level vaccination rates, the simulation model predicts measles may reestablish endemicity (83% of simulations; mean time of 20.9 years) with an estimated 851,300 cases . . . over 25 years. Under a scenario with a 10% decline in measles-mumps-rubella (MMR) vaccination, the model estimates 11.1 million . . . cases of measles over 25 years, whereas the model estimates only 5800 cases . . . with a 5% increase in MMR vaccination. . . .

Conclusions and Relevance: Based on estimates from this modeling study, declining childhood vaccination rates will increase the frequency and size of outbreaks of previously eliminated vaccine-preventable infections, eventually leading to their return to endemic levels. The timing and critical threshold for returning to endemicity will differ substantially by disease, with measles likely to be the first to return to endemic levels and may occur even under current vaccination levels without improved vaccine coverage and public health response. These findings support the need to continue routine childhood vaccination at high coverage to prevent resurgence of vaccine-preventable infectious diseases in the US.

To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, May 7 at 4:00 p.m. (ET) or Thursday, May 8 at 12:00 p.m. (ET). The same content will be covered in both sessions.

We will open each 45-minute session with a short, live demonstration on navigating our affiliated websites, including our educational website for the public, VaccineInformation.org. You can submit questions when you register or live on Zoom during the session.

Register today for Immunize​.org Website Office Hours (content is the same for both):

• Wednesday, May 7 at 4:00 p.m. (ET)
• Thursday, May 8 at 12:00 p.m. (ET)

The archive of previous Website Office Hours content is posted at Immunize​.org’s Webinars & Videos page. These archived webinars include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Images, Webinars, Videos, & Social Media; Official Guidance; Publication Archives, Vaccine Timeline, & About Us; Travel Vaccines, Vaccine Confidence, & Addressing Concerns; and Vaccines A–Z.

Mark your calendar for future Immunize​.org Website Office Hours.